Jason Rickard Ironwood Pharmaceuticals Inc (IRWD) insider trading activity

Jason Rickard is SVP, Chief Operating Officer of IRONWOOD PHARMACEUTICALS INC. Currently has a direct ownership of 376,316 shares of IRWD, which is worth approximately $1.67 Million. The most recent transaction as insider was on Mar 08, 2023, when has been sold 43,668 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 376K

0% 3M change

0% 12M change

Total Value Held $1.67 Million

Jason Rickard Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 08 2023	BUY Grant, award, or other acquisition	-	43,668 Added 10.4%	376,316 Class A Common Stock
Feb 28 2023	SELL Open market or private sale	$197,121 $11.31 p/Share	17,429 Reduced 4.98%	332,648 Class A Common Stock
Feb 27 2023	SELL Open market or private sale	$191,071 $11.41 p/Share	16,746 Reduced 4.57%	350,077 Class A Common Stock
Jan 17 2023	BUY Grant, award, or other acquisition	-	18,087 Added 4.7%	366,823 Class A Common Stock
Dec 14 2022	SELL Open market or private sale	$334,530 $12.39 p/Share	27,000 Reduced 7.19%	348,736 Class A Common Stock
Aug 15 2022	SELL Open market or private sale	$11,699 $11.77 p/Share	994 Reduced 0.26%	375,736 Class A Common Stock
Aug 09 2022	SELL Open market or private sale	$211,982 $11.75 p/Share	18,041 Reduced 4.57%	376,730 Class A Common Stock
Aug 09 2022	BUY Exercise of conversion of derivative security	$210,178 $11.65 p/Share	18,041 Added 4.37%	394,771 Class A Common Stock
Aug 08 2022	SELL Open market or private sale	$341,458 $11.6 p/Share	29,436 Reduced 7.25%	376,730 Class A Common Stock
May 23 2022	SELL Open market or private sale	$155,676 $11.5 p/Share	13,537 Reduced 3.24%	404,074 Class A Common Stock
Mar 02 2022	BUY Grant, award, or other acquisition	-	90,498 Added 17.81%	417,611 Class A Common Stock
Feb 28 2022	SELL Open market or private sale	$311,921 $10.77 p/Share	28,962 Reduced 8.13%	327,113 Class A Common Stock
Jan 19 2022	BUY Grant, award, or other acquisition	-	36,174 Added 9.22%	356,075 Class A Common Stock
Dec 16 2021	SELL Open market or private sale	$304,560 $11.28 p/Share	27,000 Reduced 7.78%	319,901 Class A Common Stock
Nov 23 2021	SELL Open market or private sale	$199,095 $11.58 p/Share	17,193 Reduced 4.75%	344,665 Class A Common Stock
Aug 16 2021	SELL Open market or private sale	$9,166 $13.48 p/Share	680 Reduced 0.19%	361,858 Class A Common Stock
May 24 2021	SELL Open market or private sale	$6,321 $12.25 p/Share	516 Reduced 0.14%	362,538 Class A Common Stock
Mar 26 2021	BUY Grant, award, or other acquisition	-	56,372 Added 13.44%	363,054 Class A Common Stock
Feb 26 2021	SELL Open market or private sale	$124,361 $9.11 p/Share	13,651 Reduced 4.26%	306,682 Class A Common Stock
Feb 22 2021	BUY Grant, award, or other acquisition	-	84,951 Added 20.96%	320,333 Class A Common Stock
Nov 09 2020	SELL Open market or private sale	$4,302 $10.92 p/Share	394 Reduced 0.17%	235,382 Class A Common Stock

Jason Rickard

SVP, Chief Operating Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IRWD shares.

Notify only if

Value

Insider Trading

Get notified when an Ironwood Pharmaceuticals Inc insider buys or sells IRWD shares.

Notify only if

Operation

Value

Type

News

Receive news related to IRONWOOD PHARMACEUTICALS INC

Track Activities on IRWD

Account